Product image of Maintelyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr) supplied by GNH India

Maintelyte

Active Ingredient:
Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr
Origin:
EU

Maintelyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

Magnesium Chloride Hexahydrate, the active ingredient in Maintelyte, is an electrolyte solution presented as an intravenous solution for parenteral use. It provides essential electrolytes and glucose to correct fluid and electrolyte imbalances in patients requiring intravenous therapy, such as those with hypomagnesemia, hypokalemia, or hyponatremia.

GNH India supplies Maintelyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product conforms to European Union quality standards and is manufactured under strict GMP conditions.

Manufacturer / TM Owner

Baxter Hellas

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Maintelyte is an intravenous electrolyte solution used in clinical situations that involve fluid loss or electrolyte disturbances.

  • Electrolyte replacement: restores depleted electrolytes in patients with systemic losses.
  • Fluid resuscitation: supplies volume and electrolytes to patients in shock or dehydration.
  • Correction of hypomagnesemia: raises serum magnesium levels in deficient individuals.
  • Correction of hypokalemia: replenishes potassium to normalize cardiac and muscular function.
  • Correction of hyponatremia: increases sodium concentration to address low serum sodium.

How It Works

  • Maintelyte delivers water, sodium, potassium, magnesium, chloride, glucose and acetate directly into the bloodstream. The supplied ions restore extracellular electrolyte concentrations, supporting osmotic balance and cellular function, while glucose provides an energy substrate. Acetate is metabolized to bicarbonate, helping to correct mild acidosis. Together, these components correct fluid deficits and electrolyte imbalances.

Side Effects

Common Side Effects

  • Infusion site pain or irritation.
  • Mild hypernatremia or hyperkalemia.
  • Mild hypocalcemia.
  • Nausea or vomiting.
  • Headache.
  • Transient flushing.

Serious or Rare Side Effects

  • Severe hypermagnesemia leading to respiratory depression.
  • Severe hyperkalemia causing cardiac arrhythmia.
  • Anaphylactic or severe allergic reaction.
  • Fluid overload with pulmonary edema.
  • Electrolyte imbalance resulting in seizures.
  • Severe hypotension or shock.

Precautions & Warnings

Before initiating therapy, evaluate the patient's baseline electrolyte profile and renal function.

  • Assess electrolyte levels before administration: check serum Mg, K, Na.
  • Monitor cardiac function during infusion: watch for arrhythmias.
  • Adjust infusion rate in renal impairment: reduce volume as needed.
  • Avoid rapid infusion in heart failure: risk of fluid overload.
  • Use compatible IV sets: ensure no precipitation with calcium-containing solutions.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Maintelyte may interact with other medications that affect electrolyte balance or renal function.

Major Interactions (Avoid)

  • Calcium‑containing solutions: can precipitate magnesium.
  • Loop diuretics: may exacerbate electrolyte shifts.
  • ACE inhibitors: increase risk of hyperkalemia.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask signs of electrolyte imbalance.
  • Nephrotoxic antibiotics: monitor renal function closely.
  • Blood transfusions: watch electrolyte levels during and after transfusion.

Frequently Asked Questions

Maintelyte is an intravenous electrolyte solution used to replace lost fluids and essential electrolytes, support patients with hypomagnesemia, hypokalemia, hyponatremia, and to provide rapid fluid resuscitation in cases of dehydration or shock.

Magnesium Chloride Hexahydrate supplies magnesium ions that are vital for enzymatic reactions, nerve conduction, and muscle contraction. In the solution, it helps restore normal serum magnesium levels, contributing to overall electrolyte balance when administered intravenously.

The dose of Maintelyte is determined by the prescribing clinician based on the patient’s electrolyte deficits, fluid status, weight, and clinical condition. The healthcare professional sets the infusion rate and total volume required for each individual case.

Safety data for Maintelyte in pregnancy and lactation are limited. Use should be considered only if the potential benefit justifies any potential risk to the fetus or infant, and it should be administered under medical supervision.

To order Maintelyte, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Maintelyte offers a balanced combination of magnesium, potassium, sodium, chloride, glucose and acetate, making it suitable for a broad range of electrolyte deficiencies. Compared with simpler saline solutions, it provides additional magnesium and potassium, reducing the need for separate supplementation in many clinical scenarios.

Maintelyte should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the container in its original packaging until use to maintain sterility and stability.

Maintelyte is administered intravenously using a sterile infusion set. The infusion rate and total volume are prescribed by the treating clinician, who may adjust the speed based on the patient’s cardiac and renal status.

Serious risks include severe hypermagnesemia or hyperkalemia, which can cause respiratory depression or cardiac arrhythmias, as well as fluid overload leading to pulmonary edema. Prompt monitoring of electrolyte levels and cardiac function is essential during therapy.

Maintelyte should be avoided in patients with known hypersensitivity to any component, severe renal impairment where electrolyte excretion is compromised, uncontrolled heart failure at risk of fluid overload, or in those receiving incompatible calcium‑containing IV solutions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.